China Universal Asset Management Company’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
China Universal Asset Management Company's ANAB Position: Q2 2026 in Review
China Universal Asset Management Company reduced its AnaptysBio (ANAB) stake by 25% in Q2 2026, selling an estimated $92.9K and leaving 4,631 shares worth $313K. The position accounts for 0.02% of the portfolio, ranked #313.
China Universal Asset Management Company first reported a position in ANAB in Q3 2022 and has held it in 16 quarters since. The position peaked at $364K in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- China Universal Asset Management Company held 4,631 shares of AnaptysBio worth $313K as of Q2 2026.
- China Universal Asset Management Company sold 1,533 AnaptysBio shares in Q2 2026, an estimated $92.9K.
- AnaptysBio made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #313 holding.
- China Universal Asset Management Company first reported a position in AnaptysBio in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's AnaptysBio position peaked at $364K in Q4 2025.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.